Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS) [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 trial evaluating rifapentine plus isoniazid (3HP) as TB preventive therapy for children on dolutegravir-based antiretroviral t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)
  • rifapentine (rifapentine)

Snippet

Sponsor: The Aurum Institute NPC | Conditions: Tuberculosis, HIV | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING